Blog
7 min read

How to Value Cyclical Stocks Without Guessing

Learn how to value cyclical stocks using normalized earnings, balance-sheet tests, and filing evidence to set a conservative margin-of-safety range properly.

A cyclical company can look cheapest precisely when it is most expensive. At the top of a cycle, earnings are elevated, valuation multiples compress, and a stock may appear to trade at six or seven times earnings. Treating that number as normal is one of the fastest ways to overpay. To understand how to value cyclical stocks, start by separating temporary earnings power from durable earning power.

The task is less about forecasting the next commodity price, housing start, or freight rate. It is about identifying what the business has earned through a full cycle, whether it can survive the next downturn, and what price leaves room for analytical error.

Why trailing P/E fails for cyclical businesses

A trailing price-to-earnings ratio assumes recent earnings are a useful proxy for future earnings. That assumption breaks down in industries where profits are driven by capacity utilization, selling prices, input costs, or credit conditions. Steelmakers, homebuilders, chemical producers, airlines, semiconductor manufacturers, energy producers, and industrial distributors can all report sharp profit changes without a comparable change in their long-term competitive position.

Consider a company earning $12 per share during an unusually favorable year. At $84 per share, it trades at 7 times trailing earnings. If normalized earnings are closer to $5 per share, however, the same stock is effectively valued at nearly 17 times earnings. The apparent bargain was created by the denominator, not the price.

The reverse can also occur near a trough. A sound business may report depressed earnings or a loss after a collapse in volume or pricing, making its P/E ratio meaningless or optically high. That does not automatically make it cheap. A trough must be temporary, and the company must have the balance sheet to reach the recovery.

How to value cyclical stocks with normalized earnings

Normalized earnings are an estimate of what the business can earn under reasonably ordinary industry conditions. They are not an invitation to choose a flattering number. The discipline comes from using a long record and making each adjustment explicit.

Start with at least one full business cycle, generally seven to ten years where the data permits. Review revenue, gross margin, operating margin, operating income, interest expense, taxes, capital expenditures, and share count. A ten-year average can be useful, but it is not automatically correct. A period containing a structural disruption, a major acquisition, an accounting change, or a prolonged commodity supercycle may require closer judgment.

The question is not simply, “What is the average?” Ask what conditions produced each result. Did margins expand because the company improved its cost position, or because industry pricing rose faster than costs? Did earnings rise after repurchases reduced the share count, or did operating profit actually improve? Did a large gain, asset sale, tax benefit, or reversal of a prior charge inflate net income?

Operating income often provides a cleaner starting point than net income because it reduces the distortion from financing choices and one-time tax items. From there, compare operating margins across the cycle. If a company historically earns a 7% operating margin but produced 15% in the last two years, a conservative valuation should not capitalize 15% as though it were permanent.

For businesses with volatile revenue, a normalized margin applied to a conservative revenue base can be more useful than averaging earnings per share. For example, use a mid-cycle revenue estimate, a margin observed in ordinary rather than exceptional years, normalized taxes, and a fully diluted share count. The result will be imperfect. It is still more defensible than pretending the latest quarter represents a steady state.

Use ranges, not a single precise answer

Cyclical valuation has too many moving parts for false precision. Build a low, base, and high estimate of normalized earnings, then apply a reasonable valuation multiple to each. The low case should reflect weaker but plausible operating conditions, not a catastrophe. The high case should require evidence of a durable business improvement, not merely an optimistic industry forecast.

This produces an intrinsic-value range rather than a target price dressed up as certainty. The range is useful because it forces the investor to confront sensitivity. If a modest change in normalized margin cuts estimated value in half, the investment case depends heavily on a condition that may not persist.

Treat the balance sheet as part of valuation

In a cyclical business, debt is not just a financing detail. It determines whether shareholders can wait for normalization. A company that appears inexpensive on mid-cycle earnings may be vulnerable if falling prices or volumes cause a covenant breach, a distressed equity issuance, or asset sales at unfavorable prices.

Review net debt relative to conservative earnings, not peak EBITDA. Examine the maturity schedule, variable-rate exposure, lease obligations, pension liabilities, and working-capital demands. Inventory and receivables can consume cash at the wrong time. Capital-intensive companies also need maintenance spending even when profits fall.

The cash flow statement matters here. Compare cumulative operating cash flow with cumulative net income over several years. Persistent gaps deserve an explanation. In some cyclical industries, working-capital swings are normal. But a company that repeatedly reports attractive earnings while requiring increasing debt or equity to fund operations has a weaker claim on intrinsic value.

Asset values can offer a second check, particularly for companies with tangible, replaceable assets. Yet book value is not a floor by default. Mines, plants, aircraft, and inventories can be worth far less than their carrying values when returns on capital are poor or industry capacity is excessive. Use asset value as supporting evidence, then ask what those assets can earn across a cycle.

Separate a cycle from a structural decline

Not every downturn is cyclical. Some are evidence that the economics of the business have changed. A company may lose pricing power to lower-cost competitors, face permanent demand erosion, or carry an asset base built for a market that no longer exists. Calling this a “temporary trough” is an analytical shortcut, not a valuation method.

Read the annual reports and quarterly filings for capacity additions, customer concentration, contract terms, impairments, restructuring charges, pension assumptions, and changes in segment reporting. Compare management's earnings-call language with the formal disclosures. Executives may characterize pressure as temporary while the filing describes lost customers, excess capacity, or uncertainty around demand and pricing.

This is where a filing-first process is useful. The issue is not whether management sounds confident. The issue is whether the documented operating record, risk disclosures, and cash generation support the claim. Hety is built around that distinction: reported evidence first, narrative second.

Choose the multiple with skepticism

After normalizing earnings, investors still need to decide what multiple those earnings deserve. A cyclical company with low returns on capital, heavy reinvestment needs, and a leveraged balance sheet should not receive the same multiple as a durable consumer franchise. The fact that both earn $5 per share in a mid-cycle year does not make them economically comparable.

Look at return on invested capital through the cycle, not only in prosperous years. Consider whether the company has a cost advantage, valuable reserves, long-term customer relationships, disciplined capacity behavior, or other evidence that it can earn above-average returns. Also examine capital allocation. Repurchasing shares at cycle peaks, making expensive acquisitions, or maintaining an unsustainable dividend can destroy value even when operations recover.

A lower multiple may be appropriate when earnings are volatile, debt is meaningful, or the industry has a history of overbuilding capacity. That is not pessimism. It is recognition that the owner of a cyclical business bears more uncertainty than the owner of a stable one.

Demand a larger margin of safety

The final protection is price. Because normalized earnings are estimates, cyclical stocks usually warrant a wider margin of safety than stable businesses. The appropriate discount depends on balance-sheet risk, quality of assets, management's record, and the reliability of the normalization work. There is no universal percentage.

Be especially careful when a stock is cheap only under the base or high case. A disciplined purchase should remain plausible under a conservative earnings assumption. If the valuation requires peak margins, a fast recovery, or refinancing on favorable terms, the margin of safety is probably illusory.

Past cycles do not guarantee future outcomes, and no valuation model removes uncertainty. But a careful owner does not need to predict the precise turn in the cycle. They need evidence that the business can endure the downturn, a conservative estimate of ordinary earning power, and a price that does not demand perfection.

See the best undervalued deals on the market.

You are not going to read the balance sheet. You don’t have three hours per company to do it, and you shouldn’t have to.

Hety runs the value investor checklists you would have to run by hand, now expanded to the NYSE and Nasdaq:

  • Intrinsic value range — what the company is actually worth, not what the market says.
  • Graham tests — the same criteria Benjamin Graham used to separate real bargains from value traps.
  • A filings cross-check — what management claimed on the earnings call, verified against what they actually filed with the SEC.

No stock tips. No “hot picks.” Just the stocks where the price and reality have drifted apart — with the reasoning shown, so you can verify it yourself in minutes not hours.

See this week's most undervalued stocks — free

Free to start · no signup · no card · $29/month for the full list